BG103905A - Врс пептидни соли с органозащитна активност, метод за получаването им и използването им в медицината - Google Patents

Врс пептидни соли с органозащитна активност, метод за получаването им и използването им в медицината

Info

Publication number
BG103905A
BG103905A BG103905A BG10390599A BG103905A BG 103905 A BG103905 A BG 103905A BG 103905 A BG103905 A BG 103905A BG 10390599 A BG10390599 A BG 10390599A BG 103905 A BG103905 A BG 103905A
Authority
BG
Bulgaria
Prior art keywords
organoprotective
medicine
activity
preparation
application
Prior art date
Application number
BG103905A
Other languages
English (en)
Other versions
BG64023B1 (bg
Inventor
Predrag Sikiric
Marijan Petek
Sven Seiwerth
Branko Turkovic
Zeljko Grabarevic
Ivo Rotkvic
Stjepan Mise
Marko Duvnjak
Ivan Udovicic
Original Assignee
Predrag Sikiric
Marijan Petek
Sven Seiwerth
Branko Turkovic
Zeljko Grabarevic
Ivo Rotkvic
Stjepan Mise
Marko Duvnjak
Ivan Udovicic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Predrag Sikiric, Marijan Petek, Sven Seiwerth, Branko Turkovic, Zeljko Grabarevic, Ivo Rotkvic, Stjepan Mise, Marko Duvnjak, Ivan Udovicic filed Critical Predrag Sikiric
Publication of BG103905A publication Critical patent/BG103905A/bg
Publication of BG64023B1 publication Critical patent/BG64023B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Изобретението се отнася до нови фармацевтични състави, приложими при лечението на различни заболявания при хора и животни. Те съдържат един или повече пептиди.
BG103905A 1997-05-23 1999-11-19 Врс пептидни соли с органозащитна активност, метод за получаването им и използването им в медицината BG64023B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97108384 1997-05-23
PCT/EP1998/002953 WO1998052973A1 (en) 1997-05-23 1998-05-20 New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy

Publications (2)

Publication Number Publication Date
BG103905A true BG103905A (bg) 2000-07-31
BG64023B1 BG64023B1 (bg) 2003-10-31

Family

ID=8226822

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103905A BG64023B1 (bg) 1997-05-23 1999-11-19 Врс пептидни соли с органозащитна активност, метод за получаването им и използването им в медицината

Country Status (28)

Country Link
US (1) US6288028B1 (bg)
EP (1) EP0983300B1 (bg)
JP (1) JP3492381B2 (bg)
KR (1) KR100488038B1 (bg)
CN (1) CN1166683C (bg)
AR (1) AR011478A1 (bg)
AT (1) ATE277948T1 (bg)
AU (1) AU731317B2 (bg)
BG (1) BG64023B1 (bg)
BR (1) BR9809457B1 (bg)
CA (1) CA2290739C (bg)
CZ (1) CZ299423B6 (bg)
DE (1) DE69826653T2 (bg)
DK (1) DK0983300T3 (bg)
EA (1) EA002058B1 (bg)
ES (1) ES2229507T3 (bg)
HU (1) HU227800B1 (bg)
ID (1) ID23184A (bg)
IL (2) IL132884A0 (bg)
NO (1) NO321126B1 (bg)
NZ (1) NZ501323A (bg)
PL (1) PL193790B1 (bg)
PT (1) PT983300E (bg)
RS (1) RS49733B (bg)
SK (1) SK159599A3 (bg)
TR (1) TR199902866T2 (bg)
UA (1) UA61955C2 (bg)
WO (1) WO1998052973A1 (bg)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070160697A1 (en) * 2004-02-27 2007-07-12 Hiroshi Kobayashi Cancer metastasis inhibitory composition
US8022216B2 (en) * 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
SI24318A (sl) * 2013-03-13 2014-09-30 Diagen D.O.O. Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji
US10350293B2 (en) 2016-08-23 2019-07-16 Pharmacotherapia d.o.o. Compositions and methods for treating symptoms associated with multiple sclerosis
KR102665710B1 (ko) 2017-08-24 2024-05-14 노보 노르디스크 에이/에스 Glp-1 조성물 및 그 용도
US20230082544A1 (en) 2020-02-18 2023-03-16 Novo Nordisk A/S Pharmaceutical formulations
US11065298B1 (en) * 2020-04-24 2021-07-20 Chanda Zaveri Compositions and methods for treating or preventing viral infections
US11833189B1 (en) * 2023-05-15 2023-12-05 Red Mountain Med Spa, LLC Sublingual Semaglutide-BPC 157 combination for weight loss

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU217541B (hu) * 1990-09-11 2000-02-28 Marko Duvnjak Farmakológiailag hatásos BPC fehérje és eljárás ennek előállítására, valamint ezt tartalmazó gyógyszerkészítmény
DE69219590T2 (de) * 1992-05-30 1997-11-27 Marko Duvnjak BPC-Peptide, deren Herstellung und Verwendung
CA2127553C (en) 1992-11-16 2003-01-28 Predrag Sikiric Peptides with organo-protective activity, process for their preparation and their use in the therapy

Also Published As

Publication number Publication date
CN1257510A (zh) 2000-06-21
JP2000515558A (ja) 2000-11-21
NO995692D0 (no) 1999-11-19
YU60199A (sh) 2002-09-19
PT983300E (pt) 2005-02-28
AR011478A1 (es) 2000-08-16
AU7914198A (en) 1998-12-11
CZ9904142A3 (cs) 2002-03-13
ATE277948T1 (de) 2004-10-15
RS49733B (sr) 2008-04-04
CN1166683C (zh) 2004-09-15
DK0983300T3 (da) 2005-01-31
HU227800B1 (en) 2012-03-28
PL336897A1 (en) 2000-07-17
WO1998052973A1 (en) 1998-11-26
KR100488038B1 (ko) 2005-05-09
JP3492381B2 (ja) 2004-02-03
HUP0002329A1 (hu) 2000-12-28
NO321126B1 (no) 2006-03-20
IL132884A0 (en) 2001-03-19
EA002058B1 (ru) 2001-12-24
NZ501323A (en) 2001-04-27
EP0983300A1 (en) 2000-03-08
EA199901061A1 (ru) 2000-06-26
IL132884A (en) 2007-08-19
BR9809457B1 (pt) 2010-11-30
AU731317B2 (en) 2001-03-29
CA2290739C (en) 2007-06-26
HUP0002329A3 (en) 2001-03-28
DE69826653T2 (de) 2006-03-09
BG64023B1 (bg) 2003-10-31
UA61955C2 (en) 2003-12-15
BR9809457A (pt) 2000-06-20
DE69826653D1 (de) 2004-11-04
KR20010012895A (ko) 2001-02-26
US6288028B1 (en) 2001-09-11
TR199902866T2 (xx) 2000-02-21
PL193790B1 (pl) 2007-03-30
ID23184A (id) 2000-03-23
NO995692L (no) 2000-01-24
CZ299423B6 (cs) 2008-07-23
ES2229507T3 (es) 2005-04-16
EP0983300B1 (en) 2004-09-29
SK159599A3 (en) 2000-11-07
CA2290739A1 (en) 1998-11-26

Similar Documents

Publication Publication Date Title
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
CA2257133A1 (en) Human dnase i hyperactive variants
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
ATE306931T1 (de) Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer
ATE242633T1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
BG103552A (bg) Терапевтични средства
HK1019856A1 (en) Therapeutic uses of bpi protein products for human meningococcemia
HUP9800049A3 (en) Amino acid compositions and use thereof in clinical nutrition, and use of the said amino acids for preparing pharmaceutical compns. for the diminution of tnf
DE69719754D1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
HUT66309A (en) Bpc peptides, their preparation and therapeutic use
BG105275A (bg) Производни на tan-1057
BG103905A (bg) Врс пептидни соли с органозащитна активност, метод за получаването им и използването им в медицината
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
CA2319542A1 (en) The treatment of sexual dysfunction in certain patient groups
EP0821969A3 (en) Medicinal Composition comprising TCF-II
DE69816808D1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
IL110888A0 (en) Pharmaceutical compositions for the treatment of liver diseases comprising a benzothiazepine derivative
MX9604539A (es) Aminoacidos modificados para la distribucion de farmaco.
MX9800686A (es) Nueva proteina hmw humana mp52s.
ZA941772B (en) Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases
IL121680A0 (en) Therapeutic substance for use in the treatment of and in the preparation of pharmaceutical compositions for the treatment of immuno-allergical diseases